AN2 Therapeutics, Inc ANTX IPO will take place March, 25 on the NASDAQ exchange under the ticker ANTX.
The company is offering shares at an expected price between $14.00 and $16.00 per share with an insider lock-up period of 180 days ending on September 21, 2022.
See also: Benzinga IPO Calendar
About AN2 Therapeutics, Inc
AN2 Therapeutics, Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs
See also: Benzinga's Most Shorted Stocks
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.